Comprehensive analysis of CYP2D6 mutations in human cancers

被引：0
|
作者：
Kuchinski, Kennedy [1 ]
Driggers, Julia [1 ]
Vo, Martin [2 ]
Escorcia, Wilber [1 ]
Wetzel, Hanna [1 ]
机构：
[1] Xavier Univ, Cincinnati, OH 45207 USA
[2] Lake Erie Coll Osteopath Med, Erie, PA USA
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2023年 / 385卷
关键词：
D O I：
10.1124/jpet.122.245260
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
232
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Analysis of CYP2D6 genotype and response to tetrabenazine
    Mehanna, Raja
    Hunter, Christine
    Davidson, Anthony
    Jimenez-Shahed, Joohi
    Jankovic, Joseph
    MOVEMENT DISORDERS, 2013, 28 (02) : 210 - 215
  • [32] Complexities of CYP2D6 gene analysis and interpretation
    Gaedigk, Andrea
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2013, 25 (05) : 534 - 553
  • [33] Molecular dynamics analysis of CYP2D6 polymorphisms
    DeWaal, Parker
    Furge, Laura
    FASEB JOURNAL, 2014, 28 (01):
  • [34] Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevity Role of CYP2D6 and CYP2C19 in longevityRole of CYP2D6 and CYP2C19 in longevity
    L. Bathum
    K. Andersen-Ranberg
    J. Boldsen
    K. Brøsen
    B. Jeune
    European Journal of Clinical Pharmacology, 1998, 54 : 427 - 430
  • [35] Frequencies of three CYP2D6 nonfunctional alleles (CYP2D6*3,*4, and*6), and the metabolic capacity of CYP2D6 in Northern Iranian Population (Mazandaran)
    Shiran, Mohammad R.
    Soteh, Mohammad B. Hashemi
    Merat, Fatemeh
    Sarzare, Fatemeh
    Salehifar, Ebrahim
    DRUG METABOLISM REVIEWS, 2010, 42 : 260 - 261
  • [36] Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population
    Griese, EU
    Asante-Poku, S
    Ofori-Adjei, D
    Mikus, G
    Eichelbaum, M
    PHARMACOGENETICS, 1999, 9 (06): : 715 - 723
  • [37] The CYP2D6 humanized mouse:: Effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse
    Corchero, J
    Granvil, CP
    Akiyama, TE
    Hayhurst, GP
    Pimprale, S
    Feigenbaum, L
    Idle, JR
    Gonzalez, FJ
    MOLECULAR PHARMACOLOGY, 2001, 60 (06) : 1260 - 1267
  • [38] The Impact of CYP2D6 metabolizer phenotypes on the EDDP/methadone metabolic ratio: A comprehensive analysis
    Wilmes, Verena
    Kettner, Mattias
    Corvest, Eva
    Verhoff, Marcel A.
    Kauferstein, Silke
    FORENSIC SCIENCE INTERNATIONAL, 2025, 370
  • [39] EVALUATION OF A TEMPLATE MODEL OF THE CYP2D6 ACTIVE-SITE BY EXPERIMENTAL TESTING OF COMPOUNDS WITH RECOMBINANT HUMAN CYP2D6
    BULSARA, D
    ACKLAND, MJ
    DUNCAN, JN
    REES, SA
    ELLIS, SW
    LENNARD, MS
    TUCKER, GT
    FASEB JOURNAL, 1994, 8 (07): : A1244 - A1244
  • [40] CYP2D6*11 and challenges in clinical genotyping of the highly polymorphic CYP2D6 gene
    Skierka, Jennifer M.
    Walker, Denise L.
    Peterson, Sandra E.
    O'Kane, Dennis J.
    Black, John Logan, III
    PHARMACOGENOMICS, 2012, 13 (08) : 951 - 954
12345